ISREUR
Perspective Therapeutics, Inc.
Clinical-stage radiopharmaceutical company developing targeted alpha-particle therapies (theranostics) for cancer using Lead-212.
CUSIP: 46489V104HealthcareUS1 holder
Perspective Therapeutics, Inc.
Clinical-stage radiopharmaceutical company developing targeted alpha-particle therapies (theranostics) for cancer using Lead-212.
No insider transactions reported in the last 3 years. Look across all recorded history →